KLOW (TB-500 + BPC-157 + KPV + GHK-Cu)
Lyophilized research reference material. Released with a per-lot Certificate of Analysis. For laboratory research use only.
- All products currently listed on this site are for research purposes ONLY.
- All products sold on this website are intended for research and identification purposes only.
- These products are not intended for human dosing, injections, or ingestion.
- Peptides are strictly for laboratory, academic, or institutional research and not for human or animal consumption.
Research background
KLOW (also designated KL80) is a research blend that commonly combines the melanocortin-derived tripeptide KPV with GHK-Cu, BPC-157, and TB-500. It is studied on the rationale of pairing melanocortin-related signaling (KPV) with matrix-remodeling and repair-associated peptides.
As with other blends, no controlled studies address this specific composition; supporting evidence is drawn from separate preclinical studies of each constituent.
Summary of published scientific literature provided for laboratory research reference only. It is not a claim of safety, efficacy, or suitability for any use, and does not describe or recommend any human or veterinary use.
Selected references
- Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178.
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. International Journal of Molecular Sciences. 2018;19(7):1987.
- Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide BPC 157 and musculoskeletal soft tissue healing. Cell and Tissue Research. 2019;377(2):153-159.
Trademarks & attribution
KLOW (KL80) is a research blend; its component compounds (KPV, GHK-Cu, BPC-157, TB-500) are investigational or non-trademark-restricted. Catalyst Research Labs is not affiliated with any branded product. Supplied as reference material only.
